Changes in Local Cerebral Glucose Utilization and Dopamine Metabolism in the Rat Brain Following Acute Administration of Haloperidol
Corresponding Author
Masayoshi Kurachi M.D.
Department of Neuropsychiatry, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama
Masayoshi Kurachi, M.D., Department of Neuropsychiatry, Faculty of Medicine, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-01, Japan.Search for more papers by this authorShin-ichi Yasui M.D.
Department of Neuropsychiatry, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama
Search for more papers by this authorRyoko Shibata M.D.
Department of Neuropsychiatry, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama
Search for more papers by this authorMasahiko Murata M.D.
Department of Neuropsychiatry, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama
Search for more papers by this authorHirohumi Hagino M.D.
Department of Neuropsychiatry, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama
Search for more papers by this authorYasuyuki Tanii M.D.
Department of Neuropsychiatry, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama
Search for more papers by this authorKouichi Kurata M.D.
Department of Neuropsychiatry, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama
Search for more papers by this authorCorresponding Author
Masayoshi Kurachi M.D.
Department of Neuropsychiatry, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama
Masayoshi Kurachi, M.D., Department of Neuropsychiatry, Faculty of Medicine, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-01, Japan.Search for more papers by this authorShin-ichi Yasui M.D.
Department of Neuropsychiatry, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama
Search for more papers by this authorRyoko Shibata M.D.
Department of Neuropsychiatry, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama
Search for more papers by this authorMasahiko Murata M.D.
Department of Neuropsychiatry, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama
Search for more papers by this authorHirohumi Hagino M.D.
Department of Neuropsychiatry, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama
Search for more papers by this authorYasuyuki Tanii M.D.
Department of Neuropsychiatry, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama
Search for more papers by this authorKouichi Kurata M.D.
Department of Neuropsychiatry, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama
Search for more papers by this authorAbstract
Abstract: The effects of acute administration of haloperidol on local cerebral glucose utilization (LCGU) in 26 discrete regions of the rat brain were examined by the quantitative autoradiographic [14C] 2-deoxy-D-glucose technique and compared with the changes in dopamine (DA) metabolism in 13 brain regions examined by a high performance liquid chromatographic assay. A moderate dose (0.25 mg/kg) of acute haloperidol significantly reduced LCGU in a few brain regions; a high dose (1.0 mg/kg) reduced LCGU in 11 regions including the prefrontal cortex, thalamus and other subcortical structures, but not in the caudate putamen or accumbens nucleus. However, the levels of DA metabolite in the caudate-putamen, accumbens nucleus, prefrontal cortex, and medial thalamus were strikingly elevated with both doses of haloperidol. Thus, the changes in LCGU did not parallel presynaptic DA metabolism in terms of direction or distribution, and they might represent mainly the activities of postsynaptic sites.
References
- 1 Buchsbaum, M.S.: The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophr Bull 16: 379–389, 1990.
- 2 Carlsson, A.: Antipsychotic drugs, neurotransmitters, and schizophrenia. Am J Psychiatry 135: 164–173, 1978.
- 3 Essig, E.C. and Kilpatrick, I.C.: Influence of acute and chronic haloperidol treatment on dopamine metabolism in the rat caudate-puta-men, prefrontal cortex and amygdala. Psy-chopharmacology 104: 194–200, 1991.
- 4 Garcia-Munoz, M., Nicolaou, N.M., Tulloch, I.F., Wright, A.K. and Arbuthnott, G.W.: Feedback loop or output pathway in striato-nigral fibres. Nature 265: 363–365, 1977.
- 5 Hosokawa, S., Kato, M., Shima, F., Tobi-matsu, S. and Kuroiwa, Y.: Local cerebral glucose utilization altered in rats with unilateral electrolytic striatal lesions and modification by apomorphine. Brain Res 324: 59–68, 1984.
- 6 Jenner, P. and Marsden, C.D.: Substituted benzamide drugs as selective neuroleptic agents. Neuropharmacology 20: 1285–1293, 1981.
- 7 Kadekaro, M., Crane, A.M. and Sokoloff, L.: Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal rost ganglion in the rat. Proc Natl Acad Sci USA 82: 6010–6013, 1985.
- 8 Kennedy, C., Des Rosiers, M.H., Sakurada, O., Shinohara, M., Reivich, M., Jehle, J.W. and Sokoloff, L.: Metabolic mapping of the primary visual system of the monkey by means of the autoradiographic [14C] deoxy-glucose technique. Proc Natl Acad Sci USA 73: 4230–4234, 1976.
- 9 Kondo, Y. and Iwatsubo, K.: Diminished response of nigral dopaminergic neurons to haloperidol and morphine following lesions in the striatum. Brain Res 181: 237–240, 1980.
- 10 Konig, J.F.R. and Klippel, R.A.: The rat brain. A stereotaxic atlas of the forebrain and lower parts of the brain stem. Robert E Krieger, New York , 1963.
- 11 Kozlowski, M. and Marshall, J.: Plasticity of [14C] 2-deoxy-D-glucose incorporation into neostriatum and related structures in response to dopamine neuron damage and apomorphine replacement. Brain Res 197: 167–183, 1980.
- 12 Kuhl, D.E., Phelps, M.E., Markham, C.H., Metter, E.J., Riege, W.H. and Winter, J.: Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Ann Neurol 12: 425–434, 1982.
- 13 Kurata, K., Kurachi, M., Hasegawa, M., Kido, H. and Yamaguchi, N.: A simultaneous analytical method for catecholamines, in-doleamines, and related compounds in 11 rat brain regions. Jpn J Psychiatry Neurol 41: 291–300, 1987.
- 14 Markwell, M.A.K., Haas, S.M., Bieber, L.L. and Tolbert, N.E.: A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87: 206–210, 1978.
- 15 Matsumoto, T., Uchimura, H., Hirano, M., Kim, J.S., Yokoo, H., Shimomura, M., Nakahara, T., Inoue, K. and Oomagari, K.: Differential effects of acute and chronic administration of haloperidol on homovanillic acid levels in discrete dopaminergic areas of rat brain. Eur J Pharmacol 89: 27–33, 1983.
- 16 McCulloch, J., Savaki, H.E. and Sokoloff, L.: Distribution of effects of haloperidol on energy metabolism in the rat brain. Brain Res 243: 81–90, 1982.
- 17 Perlmutter, J.S.: New insights into the pathophysiology of Parkinson's disease: The challenge of positron emission tomography. Trends Neurosci 11: 203–208, 1988.
- 18 Pizzolato, G., Soncrant, T.T. and Rapoport, S.I.: Haloperidol and cerebral metabolism in the conscious rat: Relation to pharmacokinetics. J Neurochem 43: 724–732 1984.
- 19 Pizzolato, G., Soncrant, T.T., Larson, D.M. and Rapoport S.I.: Reduced metabolic response of the rat brain to haloperidol after chronic treatment. Brain Res 337: 1–9, 1985.
- 20 Pizzolato, G., Soncrant, T.T., Larson, D.M. and Rapoport S.I.: Stimulatory effect of the D2 antagonist sulpiride on glucose utilization in dopaminergic regions of rat brain. J Neurochem 49: 631–638, 1987.
- 21 Porrino, L.J., Burns, R.S., Crane, A.M., Palombo, E., Kopin, I.J. and Sokoloff, L.: Changes in local cerebral glucose utilization associated with Parkinson's syndrome induced by 1-methyl-4-phenyl-1,2,3,6-tetrahy-dropyridine (MPTP) in the primate. Life Sci 40: 1657–1664, 1987.
- 22 Scatton, B., Glowinski, J. and Julou, L.: Dopamine metabolism in the mesolimbic and mesocortical dopaminergic systems after single or repeated administrations of neuro-leptics. Brain Res 109: 184–189, 1976.
- 23 Scatton, B.: Differential regional development of tolerance to increase in dopamine turnover upon repeatd neuroleptic administration. Eur J Pharmacol 46: 363–369, 1977.
- 24 Schwarcz, R., Creese, I., Coyle, J.T. and Snyder, S.H.: Dopamine receptors localized on cerebral cortical afferents to rat corpus striatum. Nature 271: 766–768, 1978.
- 25 Schwartz, W.J.: A role for the dopaminergic nigro-striatal bundle in the pathogenesis of altered brain glucose consumption after lateral hypothalamic lesions. Evidence using the 14C-labeled deoxyglucose technique. Brain Res 158: 129–147, 1978.
- 26 Schwartz, W.J., Smith, C.B., Davidson, L., Savaki, H. and Sokoloff, L.: Metabolic mapping of functional activity in the hypothalamo neurohypophysial system of the rat. Science 205: 723–725, 1979.
- 27 Sokoloff, L., Reivich, M., Kennedy, C., Des Rosers, N.H., Patlak, C.S., Pettigrew, K.D., Sakurada, O. and Shinohara, M.: The [14C] deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure and normal values in the conscious and anesthetized albino rat. J Neurochem 28: 897–916, 1977.
- 28 Westerink, B.H.C. and de Vries, J.B.: On the mechanism of neuroleptic induced increase in striatal dopamine release: Brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals. Neurosci Lett 99: 197–202, 1989.
- 29 Wooten, G.F. and Collins, R.C.: Regional brain glucose utilization following intra-striatal injections of kainic acid. Brain Res 201: 173–184, 1980.
- 30 Wooten, G.F. and Collins, R.C.: Metabolic effects of unilateral lesions of the substantia nigra. J Neurosci 1: 285–291, 1981.
- 31 Wuerthele, S.M. and Moore, K.E.: Effect of systemic and intrastriatal injections of halo-peridol on striatal dopamine and DOPAC concentrations in rats pretreated by section of nigrostratal fibres. J Pharm Pharmacol 32: 507–510, 1980.
- 32
Zilles, K.: The cortex of the rat. A stereotaxic atlas. Springer,
Berlin
,
Heidelberg and New York
, 1985.
10.1007/978-3-642-70573-1 Google Scholar
